Changes of blood glucose and lipid metabolism in breast cancer patients with cancer-related fatigue during chemotherapy: a cross-sectional survey
Abstract
Objective: To cross-sectionally investigate the correlation of cancer-related fatigue (CRF) with quality of life (QoL) and physical fitness of breast carcinoma (BC) patients during chemotherapy, so as to provide reference and guidance for the future clinical development of better medical services for BC patients during chemotherapy. Methods: From February 2023 to July 2023, 400 BC patients treated at the Breast Surgery Department of the Fujian Cancer Hospital were selected as the research subjects. Physical fitness-associated indicators were investigated, including body composition, muscle function, cardiopulmonary function, and the scores of CRF Scale, QoL Questionnaire, and Exercise Self-Efficacy Scale were investigated. Further analysis was conducted on the differences in physical fitness between neoadjuvant chemotherapy (NACT) and postoperative adjuvant chemotherapy (POAC), as well as between patients with and without exercise habits. Results: Electrocardiogram showed that 244 (61.00%) had normal heart rhythm, but 29 (7.25%) still developed abnormal cardiac function. A greater number of patients receiving NACT showed low HDL-C than those undergoing POAC (P<0.05). In patients with exercise habits, there was a larger proportion of reduced hemoglobin (Hb) compared with those without exercise habits, with higher QoL questionnaire scores (P<0.05). Conclusions: CRF during chemotherapy was evident in BC patients. Among them, patients undergoing NACT show lower HDL-C levels, while those with exercise habits have lower Hb and higher QoL scores.
Copyright (c) 2025 Yaqing Liu, Zhaoyang Huang, Qingzhong Lin, Wensi Gao, Sujuan Yang, Mei Chen, Jinxia Yang
This work is licensed under a Creative Commons Attribution 4.0 International License.
The published articles will be distributed under the Creative Commons Attribution 4.0 International License (CC BY). It is allowed to copy and redistribute the material in any medium or format, and remix, transform, and build upon it for any purpose, even commercially, as long as appropriate credit is given to the original author(s), a link to the license is provided and it is indicated if changes were made. Users are required to provide full bibliographic description of the original publication (authors, article title, journal title, volume, issue, pages), as well as its DOI code. In electronic publishing, users are also required to link the content with both the original article published in Journal of Medical Biochemistry and the licence used.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.